Icosavax, Inc. (ICVX)

Icosavax, Inc. (ICVX) — VMCI valuation read

ICVX prints VMCI 32/100 inside the Healthcare sector, where the median sits at 50. The 18-point below-median delta is the cleanest single-number summary of Icosavax, Inc.'s composite stance, and in the mid-cap bucket it places the share behind the typical peer on the five-pillar mix.

On ICVX, the SEC EDGAR Form 4 stream shows no insider buys or sells in the past 30 days. Quiet tapes happen; they just remove a signal that bull and bear cases sometimes lean on for confirmation.

**Investor frame.** ICVX trades at 14.0x earnings, 22% below the Healthcare median of 18.0x; that is the value line. ROIC of 10.0% sits 0.0pp above the Healthcare median (10.0%); that is the quality line. net debt to EBITDA of 3.0x is the rate-sensitivity line to watch; that is the risk line for Icosavax, Inc. on the trailing financials.

ICVX rose 1.5% over the trailing 7 days, with a -5.9% read on a 30-day basis.